Defining “True and Non-Misleading” for Pharmaceutical Promotion

Journal of Law, Medicine and Ethics 46 (2):552-554 (2018)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 101,551

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Education, information and promotion.E. S. Snell - 1985 - In D. M. Burley & Theodore Barker Binns (eds.), Pharmaceutical medicine. Baltimore, Md., U.S.A.: E. Arnold. pp. 189.
Pharmaceutical Innovation: Law & the Public's Health.Kevin Outterson - 2009 - Journal of Law, Medicine and Ethics 37 (2):173-175.
Pharmaceutical Firms and the Right to Health.Thana Cristina de Campos & Thomas Pogge - 2012 - Journal of Law, Medicine and Ethics 40 (2):183-187.
Legally True But Misleading Statements: A Moral Dilemma.R. Kuehn Iii - 2000 - Notre Dame Journal of Law, Ethics and Public Policy 14 (1):589-620.

Analytics

Added to PP
2018-07-20

Downloads
27 (#829,749)

6 months
8 (#597,840)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Spencer Hey
Harvard University

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references